Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Source: 
Fierce Pharma
snippet: 

Gilead Sciences has the data it’ll need to start transitioning patients taking Truvada for PrEP over to Descovy, a drug with a longer patient life. But once Truvada generics hit, it might be a different story.